Schnitzer TJ, et al. Efficacy and Safety of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Hip or Knee. ACR 2018, abstract L20.
38% minder consulten door ondersteuning met app bij RA
aug 2022 | RA
jan 2022 | Osteoporose
dec 2021 | Osteoporose
sep 2021 | Osteoporose
sep 2021 | Osteoporose
aug 2021 | Osteoporose
jul 2021 | Eczeem, Huidinfecties, Psoriasis
dec 2020 | Osteoporose
dec 2020 | Osteoporose
nov 2020